Filing Details

Accession Number:
0001209191-18-049177
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-09-04 16:10:30
Reporting Period:
2018-08-30
Accepted Time:
2018-09-04 16:10:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1503802 Karyopharm Therapeutics Inc. KPTI Pharmaceutical Preparations (2834) 263931704
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1588389 Raza Mansoor Mirza C/O Karyopharm Therapeutics Inc.
85 Wells Avenue
Newton MA 02459
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-08-30 2,236 $1.49 2,236 No 4 M Direct
Common Stock Acquisiton 2018-08-30 264 $5.64 264 No 4 M Direct
Common Stock Disposition 2018-08-30 2,500 $21.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2018-08-30 2,236 $0.00 2,236 $1.49
Common Stock Stock Option (right to buy) Disposition 2018-08-30 264 $0.00 264 $5.64
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2022-12-05 No 4 M Direct
10,342 2023-09-30 No 4 M Direct
Footnotes
  1. These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on December 6, 2013, and the remaining 75% vested in 36 equal monthly installments thereafter.
  3. This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on October 1, 2014, and the remaining 75% vested in 36 equal monthly installments thereafter.